{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:21Z","timestamp":1792783401433,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"No funding"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s15010-021-01603-y","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T14:02:50Z","timestamp":1617026570000},"page":"607-616","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Characteristics of viral pneumonia in the COVID-19 era: an update"],"prefix":"10.1007","volume":"49","author":[{"given":"P.","family":"Pagliano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sellitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ascione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7398-3624","authenticated-orcid":false,"given":"Silvano","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"1603_CR1","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/S0140-6736(10)61459-6","volume":"377","author":"O Ruuskanen","year":"2011","unstructured":"Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet. 2011;377:1264\u201375. https:\/\/doi.org\/10.1016\/S0140-6736(10)61459-6.","journal-title":"Lancet"},{"key":"1603_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jcv.2007.10.029","volume":"41","author":"R Brittain-Long","year":"2008","unstructured":"Brittain-Long R, Nord S, Olofsson S, Westin J, Anderson LM, Lindh M. Multiplex real-time PCR for detection of respiratory tract infections. J Clin Virol. 2008;41:53\u20136. https:\/\/doi.org\/10.1016\/j.jcv.2007.10.029.","journal-title":"J Clin Virol"},{"key":"1603_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s15010-019-01388-1","volume":"48","author":"F B\u00e9n\u00e9zit","year":"2020","unstructured":"B\u00e9n\u00e9zit F, Loubet P, Galtier F, et al. Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter study. Infection. 2020;48:489\u201395. https:\/\/doi.org\/10.1007\/s15010-019-01388-1.","journal-title":"Infection"},{"key":"1603_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-020-01569-3","author":"A Almeida","year":"2021","unstructured":"Almeida A, Boattini M, Christaki E, et al. Comparative virulence of seasonal viruses responsible for lower respiratory tract infections: a southern European multi-centre cohort study of hospital admissions. Infection. 2021. https:\/\/doi.org\/10.1007\/s15010-020-01569-3.","journal-title":"Infection"},{"key":"1603_CR5","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1056\/NEJMe2001126","volume":"382","author":"S Perlman","year":"2020","unstructured":"Perlman S. Another decade, another coronavirus. N Engl J Med. 2020;382:760\u20132. https:\/\/doi.org\/10.1056\/NEJMe2001126.","journal-title":"N Engl J Med"},{"key":"1603_CR6","first-page":"3","volume":"28","author":"AJ Rodriguez-Morales","year":"2020","unstructured":"Rodriguez-Morales AJ, Bonilla-Aldana DK, Balbin-Ramon GJ, Rabaan AA, Sah R, Paniz-Mondolfi A, Pagliano P, Esposito S. History is repeating itself: probable zoonotic spillover as the cause of the 2019 novel coronavirus epidemic. Infez Med. 2020;28:3\u20135.","journal-title":"Infez Med"},{"key":"1603_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/1471-2334-14-321","volume":"14","author":"T Kelesidis","year":"2014","unstructured":"Kelesidis T, Mastoris I, Metsini A, Tsiodras S. How to approach and treat viral infections in ICU patients. BMC Infect Dis. 2014;14:321. https:\/\/doi.org\/10.1186\/1471-2334-14-321.","journal-title":"BMC Infect Dis"},{"key":"1603_CR8","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3389\/fimmu.2020.01660","volume":"11","author":"X Liu","year":"2020","unstructured":"Liu X, Cao W, Li T. High-dose intravenous immunoglobulins in the treatment of severe acute viral pneumonia: the known mechanisms and clinical effects. Front Immunol. 2020;11:1660. https:\/\/doi.org\/10.3389\/fimmu.2020.01660.","journal-title":"Front Immunol"},{"key":"1603_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2016.11.012","volume":"38","author":"S Jain","year":"2017","unstructured":"Jain S. Epidemiology of viral pneumonia. Clin Chest Med. 2017;38:1\u20139. https:\/\/doi.org\/10.1016\/j.ccm.2016.11.012.","journal-title":"Clin Chest Med"},{"key":"1603_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","volume":"373","author":"S Jain","year":"2015","unstructured":"Jain S, Self WH, Wunderink R, et al. Community-acquired pneumonia requiring hospitalization among US adults. N Engl J Med. 2015;373:415\u201327.","journal-title":"N Engl J Med"},{"key":"1603_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jcv.2017.07.019","volume":"95","author":"Y Alimi","year":"2017","unstructured":"Alimi Y, Lim WS, Lansbury L, Leonardi-Bee J, Nguyen-Van-Tam JS. Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe. J Clin Virol. 2017;95:26\u201335. https:\/\/doi.org\/10.1016\/j.jcv.2017.07.019.","journal-title":"J Clin Virol"},{"key":"1603_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s15010-018-1262-x","volume":"47","author":"S Topoulos","year":"2019","unstructured":"Topoulos S, Giesa C, Gatermann S, Fussen R, Lemmen S, Ewig S. Analysis of acute respiratory infections due to influenza virus A, B and RSV during an influenza epidemic 2018. Infection. 2019;47:425\u201333. https:\/\/doi.org\/10.1007\/s15010-018-1262-x.","journal-title":"Infection"},{"key":"1603_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/cid\/civ1214","volume":"62","author":"NJ Gadsby","year":"2016","unstructured":"Gadsby NJ, Russell CD, McHugh MP, Mark H, Conway Morris A, Laurenson IF, Hill AT, Templeton KE. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis. 2016;62:817\u201323. https:\/\/doi.org\/10.1093\/cid\/civ1214.","journal-title":"Clin Infect Dis"},{"key":"1603_CR14","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fmed.2019.00286","volume":"6","author":"WC Albrich","year":"2019","unstructured":"Albrich WC, Rassouli F, Waldeck F, Berger C, Baty F. Influence of older age and other risk factors on pneumonia hospitalization in Switzerland in the pneumococcal vaccine era. Front Med (Lausanne). 2019;6:286. https:\/\/doi.org\/10.3389\/fmed.2019.00286.","journal-title":"Front Med (Lausanne)"},{"key":"1603_CR15","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/23744235.2019.1592217","volume":"51","author":"YJ Kim","year":"2019","unstructured":"Kim YJ, Lee ES, Lee YS. High mortality from viral pneumonia in patients with cancer. Infect Dis (Lond). 2019;51:502\u20139. https:\/\/doi.org\/10.1080\/23744235.2019.1592217.","journal-title":"Infect Dis (Lond)"},{"key":"1603_CR16","first-page":"29","volume":"28","author":"S Antinori","year":"2020","unstructured":"Antinori S, Galimberti L, Milazzo L, Ridolfo AL. Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia. Infez Med. 2020;28:29\u201336 (PMID: 32532935).","journal-title":"Infez Med"},{"key":"1603_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s15010-020-01401-y","volume":"48","author":"ZJ Cheng","year":"2020","unstructured":"Cheng ZJ, Shan J. 2019 Novel coronavirus: where we are and what we know. Infection. 2020;48:155\u201363. https:\/\/doi.org\/10.1007\/s15010-020-01401-y.","journal-title":"Infection"},{"key":"1603_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-020-01531-3","author":"B Salzberger","year":"2020","unstructured":"Salzberger B, Buder F, Lampl B, et al. Epidemiology of SARS-CoV-2. Infection. 2020. https:\/\/doi.org\/10.1007\/s15010-020-01531-3 (In press).","journal-title":"Infection"},{"key":"1603_CR19","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1136\/jim-2018-000712","volume":"66","author":"D Dandachi","year":"2018","unstructured":"Dandachi D, Rodriguez-Barradas MC. Viral pneumonia: etiologies and treatment. J Investig Med. 2018;66:957\u201365. https:\/\/doi.org\/10.1136\/jim-2018-000712.","journal-title":"J Investig Med"},{"key":"1603_CR20","doi-asserted-by":"publisher","first-page":"200038","DOI":"10.1183\/16000617.0038-2020","volume":"29","author":"X Gu","year":"2020","unstructured":"Gu X, Zhou F, Wang Y, Fan G, Cao B. Respiratory viral sepsis: epidemiology, pathophysiology, diagnosis and treatment. Eur Respir Rev. 2020;29:200038. https:\/\/doi.org\/10.1183\/16000617.0038-2020 (PMID: 32699026).","journal-title":"Eur Respir Rev"},{"key":"1603_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s15010-020-01415-6","volume":"48","author":"P Pagliano","year":"2020","unstructured":"Pagliano P, Spera AM, Ascione T, Esposito S. Infections causing stroke or stroke-like syndromes. Infection. 2020;48:323\u201332. https:\/\/doi.org\/10.1007\/s15010-020-01415-6.","journal-title":"Infection"},{"key":"1603_CR22","doi-asserted-by":"publisher","first-page":"e0182191","DOI":"10.1371\/journal.pone.0182191","volume":"12","author":"E Casalino","year":"2017","unstructured":"Casalino E, Antoniol S, Fidouh N, et al. Influenza virus infections among patients attending emergency department according to main reason to presenting to ED: A 3-year prospective observational study during seasonal epidemic periods. PLoS ONE. 2017;12:e0182191. https:\/\/doi.org\/10.1371\/journal.pone.0182191.","journal-title":"PLoS ONE"},{"key":"1603_CR23","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1378\/chest.14-2768","volume":"149","author":"T Maruyama","year":"2016","unstructured":"Maruyama T, Fujisawa T, Suga S, et al. Outcomes and prognostic features of patients with influenza requiring hospitalization and receiving early antiviral therapy: a prospective multicenter cohort study. Chest. 2016;149:526\u201334.","journal-title":"Chest"},{"key":"1603_CR24","doi-asserted-by":"publisher","first-page":"e310","DOI":"10.1017\/S095026881900195X","volume":"147","author":"CA Minney-Smith","year":"2019","unstructured":"Minney-Smith CA, Selvey LA, Levy A, Smith DW. Post-pandemic influenza A\/H1N1pdm09 is associated with more severe outcomes than A\/H3N2 and other respiratory viruses in adult hospitalisations. Epidemiol Infect. 2019;147:e310. https:\/\/doi.org\/10.1017\/S095026881900195X.","journal-title":"Epidemiol Infect"},{"key":"1603_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2334-13-28","volume":"13","author":"WK Liu","year":"2013","unstructured":"Liu WK, Liu Q, Chen DH, et al. Epidemiology and clinical presentation of the four human parainfluenza virus types. BMC Infect Dis. 2013;13:28. https:\/\/doi.org\/10.1186\/1471-2334-13-28.","journal-title":"BMC Infect Dis"},{"key":"1603_CR26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.canlet.2015.11.014","volume":"370","author":"DP Shah","year":"2016","unstructured":"Shah DP, Shah PK, Azzi JM, Chemaly RF. Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: a systematic review. Cancer Lett. 2016;370:358\u201364. https:\/\/doi.org\/10.1016\/j.canlet.2015.11.014.","journal-title":"Cancer Lett"},{"key":"1603_CR27","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1086\/511986","volume":"195","author":"EE Walsh","year":"2007","unstructured":"Walsh EE, Peterson DR, Falsey AR. Is clinical recognition of respiratory syncytial virus infection in hospitalized elderly and high-risk adults possible? J Infect Dis. 2007;195:1046\u201351. https:\/\/doi.org\/10.1086\/511986.","journal-title":"J Infect Dis"},{"key":"1603_CR28","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/ofid\/ofaa546","volume":"7","author":"R Godefroy","year":"2020","unstructured":"Godefroy R, Giraud-Gatineau A, Jimeno MT, et al. Respiratory syncytial virus infection: Its propensity for bacterial coinfection and related mortality in elderly adults. Open Forum Infect Dis. 2020;7:546. https:\/\/doi.org\/10.1093\/ofid\/ofaa546.","journal-title":"Open Forum Infect Dis"},{"key":"1603_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cmi.2016.11.014","volume":"23","author":"P Loubet","year":"2017","unstructured":"Loubet P, Lenzi N, Valette M, et al. Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France. Clin Microbiol Infect. 2017;23:253\u20139. https:\/\/doi.org\/10.1016\/j.cmi.2016.11.014.","journal-title":"Clin Microbiol Infect"},{"key":"1603_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1378\/chest.13-1186","volume":"145","author":"B Cao","year":"2014","unstructured":"Cao B, Huang GH, Pu ZH, et al. Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia. Chest. 2014;145:79\u201386. https:\/\/doi.org\/10.1378\/chest.13-1186.","journal-title":"Chest"},{"key":"1603_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s15010-020-01484-7","volume":"49","author":"J Gu","year":"2021","unstructured":"Gu J, Su QQ, Zuo TT, Chen YB. Adenovirus diseases: a systematic review and meta-analysis of 228 case reports. Infection. 2021;49:1\u201313. https:\/\/doi.org\/10.1007\/s15010-020-01484-7.","journal-title":"Infection"},{"key":"1603_CR32","doi-asserted-by":"publisher","first-page":"e0170592","DOI":"10.1371\/journal.pone.0170592","volume":"12","author":"JY Park","year":"2017","unstructured":"Park JY, Kim BJ, Lee EJ, et al. Clinical features and courses of adenovirus pneumonia in healthy young adults during an outbreak among korean military personnel. PLoS ONE. 2017;12:e0170592. https:\/\/doi.org\/10.1371\/journal.pone.0170592.","journal-title":"PLoS ONE"},{"key":"1603_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jcv.2014.11.010","volume":"62","author":"SH Choi","year":"2015","unstructured":"Choi SH, Huh JW, Hong SB, et al. Clinical characteristics and outcomes of severe rhinovirus-associated pneumonia identified by bronchoscopic bronchoalveolar lavage in adults: comparison with severe influenza virus-associated pneumonia. J Clin Virol. 2015;62:41\u20137. https:\/\/doi.org\/10.1016\/j.jcv.2014.11.010.","journal-title":"J Clin Virol"},{"key":"1603_CR34","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1128\/JCM.06579-11","volume":"50","author":"CS Kraft","year":"2012","unstructured":"Kraft CS, Jacob JT, Sears MH, Burd EM, Caliendo AM, Lyon GM. Severity of human rhinovirus infection in immunocompromised adults is similar to that of 2009 H1N1 influenza. J Clin Microbiol. 2012;50:1061\u20133. https:\/\/doi.org\/10.1128\/JCM.06579-11.","journal-title":"J Clin Microbiol"},{"key":"1603_CR35","doi-asserted-by":"publisher","first-page":"e230229","DOI":"10.1136\/bcr-2019-230229","volume":"12","author":"QA Waqas","year":"2019","unstructured":"Waqas QA, Abdullah HMA, Khan UI, Oliver T. Human cytomegalovirus pneumonia in an immunocompetent patient: a very uncommon but treatable condition. BMJ Case Rep. 2019;12:e230229. https:\/\/doi.org\/10.1136\/bcr-2019-230229.","journal-title":"BMJ Case Rep"},{"key":"1603_CR36","doi-asserted-by":"publisher","first-page":"e037419","DOI":"10.1136\/bmjopen-2020-037419","volume":"10","author":"L Li","year":"2020","unstructured":"Li L, Hsu SH, Gu X, et al. Aetiology and prognostic risk factors of mortality in patients with pneumonia receiving glucocorticoids alone or glucocorticoids and other immunosuppressants: a retrospective cohort study. BMJ Open. 2020;10:e037419. https:\/\/doi.org\/10.1136\/bmjopen-2020-037419.","journal-title":"BMJ Open"},{"key":"1603_CR37","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3892\/etm.2014.1577","volume":"7","author":"B Dong","year":"2014","unstructured":"Dong B, Wang Y, Wang G, Wang W, Zhou H, Fu Y. A retrospective study of cytomegalovirus pneumonia in renal transplant patients. Exp Ther Med. 2014;7:1111\u20135. https:\/\/doi.org\/10.3892\/etm.2014.1577.","journal-title":"Exp Ther Med"},{"key":"1603_CR38","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/bmt.2017.11","volume":"52","author":"L Iglesias","year":"2017","unstructured":"Iglesias L, Perera MM, Torres-Mi\u00f1ana L, Pena-L\u00f3pez MJ. CMV viral load in bronchoalveolar lavage for diagnosis of pneumonia in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2017;52:895\u20137. https:\/\/doi.org\/10.1038\/bmt.2017.11.","journal-title":"Bone Marrow Transplant"},{"key":"1603_CR39","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13054-017-1731-0","volume":"21","author":"A Mirouse","year":"2017","unstructured":"Mirouse A, Vignon P, Piron P, et al. Severe varicella-zoster virus pneumonia: a multicenter cohort study. Crit Care. 2017;21:137. https:\/\/doi.org\/10.1186\/s13054-017-1731-0.","journal-title":"Crit Care"},{"key":"1603_CR40","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s15010-010-0036-x","volume":"38","author":"S Scheithauer","year":"2010","unstructured":"Scheithauer S, Manemann AK, Kr\u00fcger S, et al. Impact of herpes simplex virus detection in respiratory specimens of patients with suspected viral pneumonia. Infection. 2010;38:401\u20135. https:\/\/doi.org\/10.1007\/s15010-010-0036-x.","journal-title":"Infection"},{"key":"1603_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jinf.2018.09.010","volume":"78","author":"R Luzzati","year":"2019","unstructured":"Luzzati R, D\u2019Agaro P, Busca A, et al. Herpes simplex virus (HSV) pneumonia in the non-ventilated immunocompromised host: Burden and predictors. J Infect. 2019;78:127\u201333. https:\/\/doi.org\/10.1016\/j.jinf.2018.09.010.","journal-title":"J Infect"},{"key":"1603_CR42","doi-asserted-by":"publisher","first-page":"581521","DOI":"10.3389\/fmed.2020.581521","volume":"7","author":"R Mann","year":"2020","unstructured":"Mann R, Perisetti A, Gajendran M, Gandhi Z, Umapathy C, Goyal H. Clinical characteristics, diagnosis, and treatment of major coronavirus outbreaks. Front Med (Lausanne). 2020;7:581521. https:\/\/doi.org\/10.3389\/fmed.2020.581521.","journal-title":"Front Med (Lausanne)"},{"key":"1603_CR43","first-page":"42","volume":"28","author":"MC Brouwer","year":"2020","unstructured":"Brouwer MC, Ascione T, Pagliano P. Neurologic aspects of covid-19: a concise review. Infez Med. 2020;28:42\u20135.","journal-title":"Infez Med"},{"key":"1603_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-020-01553-x","author":"A Elabbadi","year":"2021","unstructured":"Elabbadi A, Turpin M, Gerotziafas GT, Teulier M, Voiriot G, Fartoukh M. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia. Infection. 2021. https:\/\/doi.org\/10.1007\/s15010-020-01553-x (in press).","journal-title":"Infection"},{"key":"1603_CR45","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s15010-020-01427-2","volume":"48","author":"W Du","year":"2020","unstructured":"Du W, Yu J, Wang H, Zhang X, Zhang S, Li Q, Zhang Z. Clinical characteristics of COVID-19 in children compared with adults in Shandong Province. China Infect. 2020;48:445\u201352. https:\/\/doi.org\/10.1007\/s15010-020-01427-2.","journal-title":"China Infect"},{"key":"1603_CR46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s15010-020-01474-9","volume":"49","author":"A Fumagalli","year":"2021","unstructured":"Fumagalli A, Misuraca C, Bianchi A, et al. Pulmonary function in patients surviving to COVID-19 pneumonia. Infection. 2021;49:153\u20137. https:\/\/doi.org\/10.1007\/s15010-020-01474-9.","journal-title":"Infection"},{"key":"1603_CR47","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMra050740","volume":"353","author":"A Moscona","year":"2005","unstructured":"Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med. 2005;353:1363\u201373. https:\/\/doi.org\/10.1056\/NEJMra050740.","journal-title":"N Engl J Med"},{"key":"1603_CR48","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1001\/archinte.163.14.1667","volume":"163","author":"L Kaiser","year":"2003","unstructured":"Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Ann Intern Med. 2003;163:1667\u201372.","journal-title":"Ann Intern Med"},{"key":"1603_CR49","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s10156-012-0428-1","volume":"18","author":"Y Shobugawa","year":"2012","unstructured":"Shobugawa Y, Saito R, Sato I, Kawashima T, Dapat C, Dapat IC, et al. Clinical effectiveness of neuraminidase inhibitors\u2014oseltamivir, zanamivir, laninamivir, and peramivir\u2014for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010\u20132011 influenza season in Japan. J Infect Chemother. 2012;18:858\u201364.","journal-title":"J Infect Chemother"},{"key":"1603_CR50","first-page":"Cd002744","volume":"4","author":"K Wang","year":"2012","unstructured":"Wang K, Shun-Shin M, Gill P, Perera R, Harnden A. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only). Cochrane Database Syst Rev. 2012;4:Cd002744.","journal-title":"Cochrane Database Syst Rev"},{"key":"1603_CR51","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/irv.12363","volume":"10","author":"SG Muthuri","year":"2016","unstructured":"Muthuri SG, Venkatesan S, Myles PR, et al. Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis. Influenza Other Respir Viruses. 2016;10:192\u2013204. https:\/\/doi.org\/10.1111\/irv.12363.","journal-title":"Influenza Other Respir Viruses"},{"key":"1603_CR52","first-page":"Cd00169","volume":"2","author":"T Jefferson","year":"2006","unstructured":"Jefferson T, Demicheli V, di Pietrantonj C, Rivetti D. Amantadine and rimantadine for influenza A in adults. Cochrane Database Syst Rev. 2006;2:Cd00169.","journal-title":"Cochrane Database Syst Rev"},{"key":"1603_CR53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40121-018-0188-z","volume":"7","author":"EAF Sim\u00f5es","year":"2018","unstructured":"Sim\u00f5es EAF, Bont L, Manzoni P, et al. Past, present and future approaches to the prevention and treatment of respiratory syncytial virus infection in children. Infect Dis Ther. 2018;7:87\u2013120. https:\/\/doi.org\/10.1007\/s40121-018-0188-z.","journal-title":"Infect Dis Ther"},{"key":"1603_CR54","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1345\/aph.18243","volume":"33","author":"KD Dominguez","year":"1999","unstructured":"Dominguez KD, Mercier RC. Treatment of RSV pneumonia in adults\u2013evidence of ribavirin effectiveness? Ann Pharmacother. 1999;33:739\u201341. https:\/\/doi.org\/10.1345\/aph.18243.","journal-title":"Ann Pharmacother"},{"key":"1603_CR55","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1051","author":"N Singh","year":"2020","unstructured":"Singh N, Winston DJ, Razonable RR, Lyon GM, Silveira FP, Wagener MM, Limaye AP. Cost effectiveness of preemptive therapy versus prophylaxis in a randomized clinical trial for the prevention of CMV disease in seronegative liver transplant recipients with seropositive donors. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa1051.","journal-title":"Clin Infect Dis"},{"key":"1603_CR56","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1093\/infdis\/jiz493","volume":"221","author":"E Acosta","year":"2020","unstructured":"Acosta E, Bowlin T, Brooks J, et al. Advances in the development of therapeutics for Cytomegalovirus infections. J Infect Dis. 2020;221:S32\u201344. https:\/\/doi.org\/10.1093\/infdis\/jiz493.","journal-title":"J Infect Dis"},{"key":"1603_CR57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/cid\/civ215","volume":"61","author":"V Erard","year":"2015","unstructured":"Erard V, Guthrie KA, Seo S, et al. Reduced mortality of Cytomegalovirus pneumonia after hematopoietic cell transplantation due to antiviral therapy and changes in transplantation practices. Clin Infect Dis. 2015;61:31\u20139. https:\/\/doi.org\/10.1093\/cid\/civ215.","journal-title":"Clin Infect Dis"},{"key":"1603_CR58","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/01.CCM.0000257325.88144.30","volume":"35","author":"L Papazian","year":"2007","unstructured":"Papazian L, Doddoli C, Chetaille B, et al. A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med. 2007;35:755\u201362. https:\/\/doi.org\/10.1097\/01.CCM.0000257325.88144.30.","journal-title":"Crit Care Med"},{"key":"1603_CR59","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jfma.2017.04.009","volume":"11","author":"KKW To","year":"2017","unstructured":"To KKW, Yip CCY, Yuen KY. Rhinovirus\u2014from bench to bedside. J Formos Med Assoc. 2017;11:496\u2013504. https:\/\/doi.org\/10.1016\/j.jfma.2017.04.009.","journal-title":"J Formos Med Assoc"},{"key":"1603_CR60","first-page":"198","volume":"28","author":"S Esposito","year":"2020","unstructured":"Esposito S, Noviello S, Pagliano P. Update on treatment of COVID-19: ongoing studies between promising and disappointing results. Infez Med. 2020;28:198\u2013211.","journal-title":"Infez Med"},{"key":"1603_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JEP.S255209","volume":"13","author":"P Pagliano","year":"2021","unstructured":"Pagliano P, Scarpati G, Sellitto C, Conti V, Spera AM, Ascione T, Piazza O, Filippelli A. Experimental pharmacotherapy for COVID-19: the latest advances. J Exper Pharmacol. 2021;13:1\u201313.","journal-title":"J Exper Pharmacol"},{"key":"1603_CR62","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s15010-020-01448-x","volume":"48","author":"E Durante-Mangoni","year":"2020","unstructured":"Durante-Mangoni E, Andini R, Bertolino L, Mele F, Florio LL, Murino P, Corcione A, Zampino R. Early experience with remdesivir in SARS-CoV-2 pneumonia. Infection. 2020;48:779\u201382. https:\/\/doi.org\/10.1007\/s15010-020-01448-x.","journal-title":"Infection"},{"key":"1603_CR63","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.cmi.2015.06.022","volume":"21","author":"JW Yang","year":"2015","unstructured":"Yang JW, Fan LC, Miao XY, Mao B, Li MH, Lu HW, Liang S, Xu JF. Corticosteroids for the treatment of human infection with influenza virus: a systematic review and meta-analysis. Clin Microbiol Infect. 2015;21:956\u201363. https:\/\/doi.org\/10.1016\/j.cmi.2015.06.022.","journal-title":"Clin Microbiol Infect"},{"key":"1603_CR64","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13613-020-0642-4","volume":"10","author":"MJ Tsai","year":"2020","unstructured":"Tsai MJ, Yang KY, Chan MC, et al. Impact of corticosteroid treatment on clinical outcomes of influenza-associated ARDS: a nationwide multicenter study. Ann Intensive Care. 2020;10:26. https:\/\/doi.org\/10.1186\/s13613-020-0642-4.","journal-title":"Ann Intensive Care"},{"key":"1603_CR65","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/irv.12456","volume":"11","author":"H Li","year":"2017","unstructured":"Li H, Yang SG, Gu L, et al. Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia. Influenza Other Respir Viruses. 2017;11:345\u201354. https:\/\/doi.org\/10.1111\/irv.12456.","journal-title":"Influenza Other Respir Viruses"},{"key":"1603_CR66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","author":"Recovery Collaborative Group","year":"2020","unstructured":"Recovery Collaborative Group, et al. Dexamethasone in hospitalized patients with Covid-19\u2014preliminary report. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/NEJMoa2021436.","journal-title":"N Engl J Med"},{"key":"1603_CR67","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jama.2020.17023","volume":"324","author":"WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group","year":"2020","unstructured":"WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. 2020;324:1330\u201341. https:\/\/doi.org\/10.1001\/jama.2020.17023.","journal-title":"JAMA"},{"key":"1603_CR68","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jvsv.2018.08.010","volume":"7","author":"AT Obi","year":"2019","unstructured":"Obi AT, Tignanelli CJ, Jacobs BN, Arya S, Park PK, Wakefield TW, Henke PK, Napolitano LM. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients. J Vasc Surg Venous Lymphat Disord. 2019;7:317\u201324. https:\/\/doi.org\/10.1016\/j.jvsv.2018.08.010.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"1603_CR69","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1186\/s13054-020-03375-7","volume":"24","author":"S Jonmarker","year":"2020","unstructured":"Jonmarker S, Hollenberg J, Dahlberg M, et al. Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients. Crit Care. 2020;24:653. https:\/\/doi.org\/10.1186\/s13054-020-03375-7.","journal-title":"Crit Care"},{"key":"1603_CR70","first-page":"4","volume":"28","author":"O Piazza","year":"2020","unstructured":"Piazza O. Should lCU COVID-19 patients empirically receive therapeutic doses of anticoagulant? Infez Med. 2020;28:4\u20135.","journal-title":"Infez Med"},{"key":"1603_CR71","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.thromres.2020.12.013","volume":"199","author":"A Kollias","year":"2020","unstructured":"Kollias A, Kyriakoulis KG, Syrigos NK, Stergiou GS. Anticoagulation therapy in COVID-19: is there a dose-dependent benefit? Thromb Res. 2020;199:19\u201320. https:\/\/doi.org\/10.1016\/j.thromres.2020.12.013.","journal-title":"Thromb Res"},{"key":"1603_CR72","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1469-0691.2012.03797.x","volume":"19","author":"JR Masclans","year":"2013","unstructured":"Masclans JR, P\u00e9rez M, Almirall J, Lorente L, Marqu\u00e9s A, Socias L, Vidaur L, Rello J, H1N1 GTEI\/SEMICYUC Investigators. Early non-invasive ventilation treatment for severe influenza pneumonia. Clin Microbiol Infect. 2013;19:249\u201356. https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03797.x.","journal-title":"Clin Microbiol Infect"},{"key":"1603_CR73","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/crj.12184","volume":"10","author":"A Nicolini","year":"2016","unstructured":"Nicolini A, Ferraioli G, Ferrari-Bravo M, Barlascini C, Santo M, Ferrera L. Early non-invasive ventilation treatment for respiratory failure due to severe community-acquired pneumonia. Clin Respir J. 2016;10:98\u2013103. https:\/\/doi.org\/10.1111\/crj.12184.","journal-title":"Clin Respir J"},{"key":"1603_CR74","doi-asserted-by":"publisher","first-page":"R148","DOI":"10.1186\/cc8044","volume":"13","author":"J Rello","year":"2009","unstructured":"Rello J, Rodr\u00edguez A, Iba\u00f1ez P, et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care. 2009;13:R148. https:\/\/doi.org\/10.1186\/cc8044.","journal-title":"Crit Care"},{"key":"1603_CR75","doi-asserted-by":"publisher","first-page":"e000692","DOI":"10.1136\/bmjresp-2020-000692","volume":"7","author":"A Ashish","year":"2020","unstructured":"Ashish A, Unsworth A, Martindale J, Sundar R, Kavuri K, Sedda L, Farrier M. CPAP management of COVID-19 respiratory failure: a first quantitative analysis from an inpatient service evaluation. BMJ Open Respir Res. 2020;7:e000692. https:\/\/doi.org\/10.1136\/bmjresp-2020-000692.","journal-title":"BMJ Open Respir Res"},{"key":"1603_CR76","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3389\/fphar.2020.00857","volume":"11","author":"V Giudice","year":"2020","unstructured":"Giudice V, Pagliano P, Vatrella A, et al. Combination of ruxolitinib and eculizumab for treatment of severe SARS-CoV-2-related acute respiratory distress syndrome: a controlled study. Front Pharmacol. 2020;11:857. https:\/\/doi.org\/10.3389\/fphar.2020.00857.","journal-title":"Front Pharmacol"},{"key":"1603_CR77","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/jcp.24173","volume":"228","author":"V Esposito","year":"2013","unstructured":"Esposito V, Verdina A, Manente L, et al. Amprenavir inhibits the migration in human hepatocarcinoma cell and the growth of xenografts. J Cell Physiol. 2013;228:640\u20135. https:\/\/doi.org\/10.1002\/jcp.24173.","journal-title":"J Cell Physiol"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-021-01603-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-021-01603-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-021-01603-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T13:14:15Z","timestamp":1627391655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-021-01603-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1603"],"URL":"https:\/\/doi.org\/10.1007\/s15010-021-01603-y","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,29]]},"assertion":[{"value":"26 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no affiliations with or involvement in any organization or entity with any financial or nonfinancial interest related to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}